Prosecution Insights
Last updated: April 19, 2026

Examiner: KIEFER, DALTON EDWARD

Tech Center 1600 • Art Units: 1652

This examiner grants 0% of resolved cases

Performance Statistics

%
Allow Rate
-60.0% vs TC avg
8
Total Applications
Interview Lift
1175
Avg Prosecution Days
Based on 0 resolved cases, 2023–2026

Rejection Statute Breakdown

0%
§101 Eligibility
25.0%
§102 Novelty
37.5%
§103 Obviousness
32.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18292448 METHOD FOR DIAGNOSING ACUTE EXACERBATION OF BRONCHIECTASIS AND KIT THEREFOR Non-Final OA Z BIOTECH INC.
18533181 METHOD OF USING/APPLYING A KERATIN HYDROLYSIS PEPTIDE SOLUTION TO ENAHNCE THE FLAVOR OF TEA LEAVES Non-Final OA CH Biotech R&D Co., Ltd.
18527787 KERATIN HYDROLYSIS PEPTIDE SOLUTION Non-Final OA CH Biotech R&D Co., Ltd.
18543707 METHOD FOR DETERMINING FIBRINOGEN Non-Final OA Siemens Healthcare Diagnostics Products GmbH
17995686 METHOD FOR REMOVING COLOR FROM DRUG SUBSTANCE OF PROTEIN PREPARATION Non-Final OA ONO PHARMACEUTICAL CO., LTD.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month